Class Action Article

  • Physiomesh Hernia Mesh Lawyers: Physiomesh Hernia Mesh lawyers are filing Hernia Mesh lawsuits for your failed Physiomesh used to repair your hernia. Ethicon voluntarily withdrew the Physiomesh from the  market in May of 2016  after independent studies revealed high rates...

Class Action News

  • Stryker Femoral Heads Hip Replacement Lawyers: Stryker V40 Taper Hip Replacement Lawyers Stryker Hip Replacement Lawyers Hip Implant lawyers are filing hip replacement lawsuits for V40 Femoral head failure in the Stryker Hip Implant. In August 2016, Stryker contacted implanting physic...

Drug Class Actions

  • Taxotere Lawyers for Permanent Hair Loss: Taxotere Baldness Lawyers For  Permanent Hair Loss Lawsuits Have you received Taxotere for breast cancer? Taxotere can result in hair loss or baldness  that is permanent. Taxotere  is a chemotherapy drug used for the treatment of breas...

Medical Device Lawsuits

  • File An IVC Filter Lawsuit: Our IVC Filter lawyers are filing IVC Filter lawsuits for injury and Death from a fractured migrating IVC Filter part. The IVC Filters, also known as blood clot filters, Blood Clot Capture Filters and Inferior Vena Cava Filters, are implant...

Posts Tagged ‘Deerfield’

IVC Bard Blood Clot Filers Lawyer Alert

Written by lisaspitzer on . Posted in Bard IVC Filter Lawyers

IVC Filter Lawyers Advise – Bard IVC Filter Lawsuits Consolidated

Bard IVC Filter lawsuits have been transferred to a  federal court in Arizona. IVC Filter lawyers of Class Action Lawyer Network will  help victims injured by the  defective IVC filters.

IVC Filter MDL

A transfer order filed Monday, in  the U.S. Judicial Panel on Multidistrict Litigation (JPML), resulted in  all present and future federal product liability lawsuits against inferior vena cava filter (IVC filter) manufacturers, C.R. Bard, Inc. and Bard Peripheral Vascular, Inc. (BPV),  to be centralized in a multidistrict litigation (MDL) in the District of Arizona.

What Are IVC Filters?

IVC filters are surgical implants that catch blood clots before they travel to the lungs  to avoid causing a pulmonary embolism. The Bard IVC Filter devices are  fracturing, tilting, migrating, or puncturing the vena cava.

FDA Vena Cava Filter Warnings

The U.S. Food and Drug Administration issued a safety warning in 2010, citing that  more than 900 IVC Filter adverse event reports  were filed  over  five years A study published in the April 2013 edition of Jama Internal Medicine, found that less than 10% of retrievable IVC filters surveyed were successfully removed. They also reported that   8% of persons surveyed still suffered venous thrombotic events while the IVC filter was in place. In 2014, the FDA issued an updated warning  to doctors recommending that IVC filters be removed within one to two months once the need for the filter has passed.  They noted that doctors may not have previously been made aware of the urgency surrounding retrieval of the device.

IVC Filter Lawyers

IVC filter lawyers will help you get  compensation as part of the Bard IVC filter MDL, which has been consolidated to the U.S. District Court of Arizona.  

Overview of Drugs and Medical Devices Harming Women, Lawyers Filing Lawsuits

Written by Class Action Lawyer on . Posted in Class MDL Class Action News

          Discussion presented by our female medical Social Worker

Bladder Sling, Mirena IUD, Vaginal mesh, Yaz, Yasmin, Fosamax, Topomax, DePuy hip replacement recall, Actos, Breast Implants, Tylenol, avaira toric contact lenses and others are harming women.
          It is amazing to me how many dangerous drugs and medical devices are having an effect on women. The breast Implant Helpline hears from women thru-out the country regarding their horrific experiences with these mesh devices. Yet, there are so many other drugs and medical devices that are hurting women. The Mirena birth control device, Yaz, Yasmin, Ocella, The DePuy Hip Replacement, metal on metal hip replacements, Zimmer Duram Cup, Breast Implants, Cytotec, Topamax and others,
Mirena Birth Control device

Mirena Silicone IUD
          The Mirena Birth control device has caused amongst other side effects: Miscarriage, Risk Of Infertility, Intrauterine Pregnancy, Streptococcal Sepsis, Pelvic Inflammatory Disease Cervix, Severe Pain, Contraceptive Perforation and other side effects.
Some women have experienced serious adverse side-effects and potentially life-threatening complications following the implantation of the Mirena device, including perforation of or imbedment in the uterus.
Bayer actually marketed Mirena as a way women could simplify their lifestyle. One of the ways it did so was through "Mirena Parties." Working with the social networking site Mom Central, Bayer created a Mirena direct marketing program that consisted of a series of house parties hosted by members of the Mom Central community. Bayer was eventually warned against this. The stories have heard and read regarding this device are horrific.
WARNINGS AND PRECAUTIONS
Ectopic Pregnancy
          Evaluate women who become pregnant while using Mirena for ectopic pregnancy. Up to half of pregnancies that occur with Mirena in place are ectopic. The incidence of ectopic pregnancy in clinical trials that excluded women with risk factors for ectopic pregnancy was approximately 0.1% per year.
"Tell women who choose Mirena about the risks of ectopic pregnancy, including the loss of fertility."
     Other Adverse Effects from the use of Mirena:
     Sepsis, ovarian cyst formation, breast cancer, damage to conceived children, PID, embedment, amenorrhea, perforation of uterine wall or cervix may occur during insertion

Cytotec (Misoprostol)
        It is estimated that in about 200,000 births in one year, Cytotec was used to stimulate delivery. This is where most of the problems with this drug, including birth defects have incurred. The purpose of the drug was for the prevention of ulcers, but it has also been used in abortions. Brain damage to infants is of particular concern.\

Yaz, yasmin Birth Control Pills
         Studies recently published in the British Medical Journal, which concluded that women ages 15-44 taking birth control pills containing the synthetic progestin, drospirenone, are more likely to develop blood clots deep in the veins of the leg (venous thromboembolism), than women using birth control pills containing the common progestin levonorgestrel. The studies reported that the risk of developing blood clots for women taking the drospirenone-containing pills may be two to three times greater than those who take other pills. Yaz is one of these drugs.

Potential Yasmin and Yaz side effects may cause:

  •  Heart Attacks
  • Strokes
  • Cardiac Arrhythmias
  • Blood Clots
  • Deep Vein Thrombosis (DVT)
  • Liver damage
  • Anaphylactic Shock
  • Pulmonary Embolism (PE)
  • cervical cancer
  • severe migraines
  • Hair loss
  • Gallbladder Disease
  •  Death

List of Drugs similiar to Yaz and Yasmine
         Approved Oral Contraceptives containing Drospirenone
Drospirenone and ethinyl estradiol Drospirenone 3 mg and ethinyl estradiol 0.03 mg
Ocella Drospirenone 3 mg and ethinyl estradiol 0.03 mg
Safyral Drospirenone 3 mg, ethinyl estradiol 0.03 mg, and levomefolate calcium 0.451 mg
Syeda Drospirenone 3 mg and ethinyl estradiol 0.03 mg
Yasmin Drospirenone 3 mg and ethinyl estradiol 0.03 mg
Zarah Drospirenone 3 mg and ethinyl estradiol 0.03 mg
Beyaz Drospirenone 3 mg, ethinyl estradiol 0.02 mg and levomefolate calcium 0.451 mg
Drospirenone and ethinyl estradiol Drospirenone 3 mg and ethinyl estradiol 0.02 mg
Gianvi Drospirenone 3 mg and ethinyl estradiol 0.02 mg
Loryna Drospirenone 3 mg and ethinyl estradiol 0.02 mg
Yaz Drospirenone 3 mg and ethinyl estradiol 0.02 mg

Topamax
          Topiramate, the generic form of Johnson & Johnson's anti-seizure drug, Topamax, is under fire from the Food & Drug Administration for its birth defect risks, Reuters reports. The medication is prescribed to patients suffering from epilepsy, and more popularly, to consumers with chronic migraine headaches. Topiramate has recently been combined with other drugs to battle obesity and bipolar disorder. More than 4.7 million prescriptions for Topamax were filled in the United States from 2007 to 2010, bringing in approximately $600 million worldwide last year.
In March 2011, the FDA issued a warning that Topamax side effects may increase the risk of oral cleft birth defects, such as cleft lip and cleft palate, among babies born to mothers who took the drug during the first trimester of pregnancy. As a result of inadequate warnings previously provided, many women were not aware they may be exposing their baby to a potential risk of Topamax birth defect.
If one looks att all the current medical devices and drugs with complications the effects on women are staggering:? A new report says women are most likely to be injured.

FOSAMAX EFFECTS WOMEN
         The .Long-Term use of Fosamax has been shown to more then double the Risk of Femur Fractures Among Older Women.
An article in an issue of the Journal of the American Medical Association reports that long-term use of Fosamax and other bisphosphonate drugs by older women more than doubles their chance of suffering femur fractures. This side effect is particularly disturbing in light of the fact that Fosamax and similar drugs are prescribed to strengthen the bones of women with osteoporosis.
          The article summarizes a study of Canadian women aged 68 years and older who had taken oral bisphosphonates like Fosamax for five years or more. The study found that women who had taken Fosamax and related drugs for five years or longer were 2.74 times more likely to suffer a femur fracture than women who had taken the drug for only 100 days or less. In fact, the study concluded that more than half of the femur fractures among women who had taken bisphosphonates for five years or more were attributable to their use of bisphosphonates.
         A number of Fosamax lawsuits seeking financial compensation have already been filed against Merck & Co. for injuries caused as a result of serious

TRANSVAGINAL MESH AND RELATED MESH PRODUCTS
 Manufacturers of Mesh Products Include:

  • Johnson & Johnson
  • Ethicon TVT
  • Gynecare TVT
  • Gynemesh PS
  • Prolene Polypropylene Mesh Patch
  • Secur
  • Bard
  • Avaulta Plus BioSynthetic Support System
  • Avaulta Solo Synthetic Support System
  • Faslata Allograft
  • Pelvicol Tissue
  • PelviSoft Biomesh
  • Pelvitex Polypropylene Mesh
  • American Medical Systems or AMS
  • SPARC
  • Boston Scientific
  • Advantage Sling System
  • Obtryx Curved Single
  • Obtryx Mesh Sling
  • Prefyx Mid U Mesh Sling System
  • Prefyx PPS System

           Vaginal mesh implants have been used to correct uterine prolapse and incontinence but the complications are effecting women thru-out the United States, Canada and the U.K.
complications include:

  • Erosion of vaginal tissue can result from a vaginal mesh
  • Hardening of the vaginal mesh
  • Infection is a serious vaginal mesh-patch complication
  • Severe Pain and discomfort
  • Perforations of the bowel, bladder or blood vessels
  • Recurrence of Pelvic Organ Prolapse (POP) and Stress Urinary Incontinence (SUI)
  • Urinary problems and more severe incontinence
  • painful sexual intercourse
  • Vaginal mesh erosion
  • Vaginal scarring

           The transvaginal mesh Continues to effect women and alter the lives of Women and
Recent warnings have linked various birth control drugs and devices to serious injuries and even death.

Metal On Metal Hip Replacements like the DePuy and Zimmer
          Women are reporting more problems, and a higher failure rate, with the DePuy ASR XL Acetabular hip replacement system than men. It turns out they're also more prone to some of the serious side effects of the poorly-designed implant, including metallosis.
Statistics show individuals with a small stature, such as women may be more susceptible to failure of DePuy ASR hip implants.

.
Dow Corning Breast Implants
Breast Implant Lymphoma
          In January 2011, The U.S. Food & Drug Administration (FDA) advised that women who had received breast implants should notify their doctors of any changes in their breasts because of a possible association with a rare type of lymphoma. In breast implant patients, ALCL has occurred in the scar capsule adjacent to the implant.
Symptoms of breast implant lymphoma include:

  • Pain
  • Lumps
  • Swelling

        Asymmetry that developed after their initial surgical sites were fully healed
Historically, women are more often exposed to dangerous medical products and medical negligence than men. Some medical malpractice claims, for instance, are unique to women—like obstetrical malpractice and sexual assault by health care providers. In addition, women suffer harm from gender-specific products such as breast implants, birth control pills, osteoporosis medications and birth control devices like IUDs.
In the age of prescription drugs and antidepressants, where drugs are administered over-the-counter without any major restrictions, more people are dying each year from medications than from traffic accidents. A recent L.A. Times article looked at the impact prescription drugs have upon American society, and their dangers if used in certain combinations.
In 2009, prescription drugs factored in the deaths of over 37,000 people. Less people died in motor vehicle accidents that year, which was a new phenomenon, according to the U.S. Centers for Disease Control and Prevention.
           It is hoped that the new bill coming before congress will protect women from manufacturers whose products slip thru and eventually are either recalled or end up with warnings. These drugs and medical devices are hurting women.

Actos Lawyers Filing Actos Lawsuits, Actos Linked to Bladder Cancer

Written by Class Action Lawyer on . Posted in Actos Lawsuit Lawyers, Drug Lawsuits, Multidistrict Lawsuit News

Actos Linked To Bladder Cancer

 Actos has been linked to bladder cancer with use of over 2 years.

Seniors and minority groups are usual victims of Actos. Actos is a drug used for Type II, adult onset, diabetis.

Thousands of Actos Bladder Cancer  Lawsuits Are  Anticipated

Actos Timeline Gives The Actos Lawsuit Statute  Starting Date

Jun 10, 2011: Use of Actos is banned in France and Germany. The French Medicines Agency removed the drug from the market after analyzing the data collected from 2006 to 2009.

Jun. 15, 2011: FDA announces “that use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer.” Warning labels are to be updated subsequently. The agency warns healthcare professionals against prescribing Actos in patients who have bladder cancer or have a history of bladder cancer.

Jul. 2011: The EMA states that Actos should include the risk of bladder cancer on its warning label, according to Reuters.

Aug.  4, 2011: – The FDA approves the label change for product containing pioglitazone (marketed as Actos, Actoplus Met, and Duetact) previously announced on June 15, 2011.

Actos Lawsuit  MDL Consolidation

Actos pillsThousands of Actos lawsuits are anticipated in the multidistrict litigation (MDL) filing ordered by Judge Rebecca Doherty. The honorable Judge Doherty stated in a recent order that "the number of claims which will be included could reach into the thousands," in reference to the new Actos lawsuit MDL she ordered be created. Judge Doherty is not presiding over an Actos class action lawsuit.
The MDL was created so that Judge Doherty will have one common point of reference for the thousands of cases expected. This specific MDL lets all of the affected Actos users work together so they are all essentially covered under one lawsuit (similar to a class action.) Unlike an Actos class action lawsuit, where the payout per participant may be small, an award from the Actos MDL could amount to tens or hundreds of thousands of dollars per litigant. It could even be in the million dollar range if the an Actos user's death was tied back to taking Actos and developing bladder cancer or another severe adverse side effect of Actos.

Get An Actos Lawyer

An experienced Actos attorney will be able to help determine what financial awards may be possible based on the severity of the injury and required treatment due to taking Actos.

Actos Bladder Cancer Symptoms

It's important that Actos users know what to look out for if they have taken Actos for more than one year which allegedly increases the risk of bladder cancer by at least 40%. Symptoms of bladder cancer include tumors which could cause blood in the urine, painful or frequent urination, or straining during urination. In addition, other common symptoms of bladder cancer include fatigue, incontinence, weight loss and bone pain or tenderness. If you are experiencing these symptoms you should see a doctor immediately so bladder cancer or tumors can be ruled out.

Speak To An Actos Bladder Cancer Lawyer and See Your Doctor Right Away

If you are experiencing these symptoms and are diagnosed with bladder cancer or tumors it may be a good idea to speak with an attorney to see if you are able to file an Actos lawsuit under the new MDL.

 

Bard Begins Trials for Vaginal Mesh, Vaginal Mesh Lawyers Ready

Written by Class Action Lawyer on . Posted in Medical Device Lawsuits, Transvaginal mesh

Bard Faces First Federal Trial Over Vaginal Mesh Next Year

C.R. Bard Inc. will face its first federal-court trial next year over claims that the company’s vaginal-mesh implants injured women.

U.S. District Judge Joseph R. Goodwin in Charleston, West Virginia, set a Feb. 5 trial date for the first of about 600 federal cases contending that Bard’s Avaulta device caused organ damage. Goodwin is overseeing a consolidation of cases filed in federal courts across the U.S. against Bard, Johnson & Johnson and other makers of vaginal-mesh inserts.

The order of trials for the first federal cases over Avaulta “will be determined after completion” of pretrial information exchanges between Bard and the plaintiffs, Goodwin said in his order yesterday.

Bard, based in Murray Hill, New Jersey, and a unit of New Brunswick, New Jersey-based J&J also face litigation in U.S. state courts over their mesh products. More than 75,000 women a year have the devices inserted vaginally to treat pelvic organs that bulge, or prolapse, or to deal with incontinence.

Scott Lowry, a Bard spokesman, didn’t immediately return a call for comment on the judge’s decision to set the trial date.

A U.S. Food and Drug Administration report in August 2011 found that vaginal-mesh products should be classified as posing a high risk to patients based on a review of side-effect reports submitted to regulators from January 2008 to December 2010. Women’s groups are demanding that the devices be recalled.

More Study

In January, the FDA ordered 31 manufacturers, including Bard and J&J (JNJ) (JNJ), to study rates of organ damage and complications linked to the vaginal-mesh implants. The companies must conduct three years of studies on the devices’ safety and effectiveness, regulators said. Some women contend the devices eroded and shrank over time, causing pain and injuries.

Some mesh suits blaming Bard and J&J for injuries are pending in state court in Atlantic City, New Jersey. Superior Court Judge Carol Higbee is coordinating discovery in those cases. Higbee has set a Nov. 5 trial for the first case against J&J’s Ethicon unit over claims that its Gynecare Prolift vaginal-mesh insert harmed women.

In February, the Judicial Panel on Multidistrict Litigation consolidated federal suits against pelvic mesh makers before Goodwin. The judge is overseeing evidence-gathering efforts in cases against Bard, J&J, Boston Scientific Corp. (BSX) (BSX) and the American Medical Systems unit of Endo Pharmaceutical Holdings Inc.

Endo’s AMS unit also faces claims in state courts in Delaware and Minnesota over its Perigee, Apogee and Elevate surgical mesh products, according to court filings.

‘Day In Court’

Goodwin has appointed Bryan Aylstock, Fred Thompson III and Henry G. Garrard III to lead a group of plaintiffs’ lawyers who will oversee the progress pretrial information exchanges over the consolidated federal cases.

Aylstock, a Pensacola, Florida-based lawyer, said he was pleased Goodwin set the first trial over Bard’s mesh product for early next year.

“We have a lot of women who have suffered devastating consequences from the Avaulta product and they deserve their day in court,” the plaintiffs’ lawyer said in a telephone interview.

The Bard consolidated cases are In re C.R. Bard Inc. Pelvic Repair System Products Liability Litigation, 2:10-MD-02187, U.S. District Court, Southern District of West Virginia (Charleston).

To contact the reporters on this story: Jef Feeley in Wilmington, Delaware, at jfeeley@bloomberg.net; David Voreacos in Newark, New Jersey, at dvoreacos@bloomberg.net

Multi District Litigation Vaginal Mesh  lawyers are ready to file.

Trials for failed DePuy Hip Replacements Ready to Begin, DePuy lawyers Accepting Cases Now

Written by Class Action Lawyer on . Posted in Arizona Multidistrict Litigation Lawyers, California Multidistrict Litigation Lawyers, Colorado Multidistrict Litigation Lawyers, Connecticut Multidistrict Litigation Lawyers, Florida Multidistrict Litigation Lawyers, Georgia Multidistrict Litigation Lawyers, Indiana Multidistrict Litigation Lawyers, Iowa Multidistrict Litigation Lawyers, Kansas Multidistrict Litigation Lawyers, Maryland Multidistrict Litigation Lawyers, Massachusetts Multidistrict Litigation Lawyers, Michigan Multidistrict Litigation Lawyers, Nevada Multidistrict Litigation Lawyers, New Jersey Multidistrict Litigation Lawyers, New Mexico Multidistrict Litigation Lawyers, New York Multidistrict Litigation Lawyers, North Carolina Multidistrict Litigation Lawyers

DePuy Hip Recall trials ready to begin. DePuy Hip Replacement Lawyers accepting cases in many states. If , need revision surgery or have had revision surgery or metal on  metal toxicity we want to speak to you right away. Only claim in state with 2 year statutes or greater are being accepted. Call right away as time is running out. If you have complications from your dePuy hip replacement see a doctor immediately
The first bellwether trials in the pending DePuy hip litigation are scheduled to begin later this year. The handful of plaintiffs involved in the trials represent just a few of the thousands of individuals who filed suit against Johnson & Johnson and DePuy Orthopedics after being injured by a defective metal hip implant. mny of these have been seniors needing revision surgeries.

According to a Bloomberg report, the first bellwether case is scheduled to go to trial in a Nevada court in December of this year. Additional bellwether trials are expected to begin in January 2013. According to the report, these cases are part of an estimated 2,000 DePuy hip lawsuits filed in state courts across the country. Several thousand more lawsuits are also pending in federal court after being consolidated into a multidistrict litigation (MDL) for pretrial proceedings. The plaintiffs involved in the DePuy hip litigation allege that they experienced pain, swelling, tissue damage, loss of mobility and other complications after being fitted with an ASR all-metal hip implant.  The lawsuits also allege that DePuy and Johnson & Johnson knew of potential problems with the metal hip replacement devices but did not take adequate steps to warn consumers of the dangers.

DePuy Orthopaedics issued a global recall of the ASR Hip Resurfacing System and ASR Acetabular System in August 2010, after data from the National Joint Registry of England and Wales showed that 1 out of every 8 patients (12%-13%) who had received the devices had to undergo revision surgery within five years of receiving it. According to Parker Waichman LLP, more than 93,000 metal-on-metal DePuy ASR hip implants were sold worldwide prior to their recall.

The U.S. Food & Drug Administration (FDA) is currently conducting a safety review of metal-on-metal hip implants, including the DePuy ASR devices. Last May, the agency directed 21 companies that market all-metal hip replacements, including DePuy, to conduct post-market studies of their products to determine if they were shedding dangerous amounts of metallic debris in patients. The FDA recently announced that its Orthopaedic and Rehabilitation Devices Panel will meet on June 27 and 28 to discuss the risks and benefits of metal-on-metal hip systems, and make potential patient and practitioner recommendations for their use.

It is strongly urged that anyone who has a failed DePuy see their Doctor immediately to find out if revision surgery is recommended and speak to a DePuy Lawyer right away